| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |